Scutellaria barbata D. Don Inhibits the Main Proteases (Mpro and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Authors:
- Sheng-Teng HuangSHSheng-Teng Huang
- Yeh ChenYCYeh Chen
- Wei-Chao ChangWCWei-Chao Chang
- Hsiao-Fan ChenHCHsiao-Fan Chen
- Hsiang-Chun LaiHLHsiang-Chun Lai
- Yu-Chun LinYLYu-Chun Lin
- Wei-Jan WangWWWei-Jan Wang
- Yu-Chuan WangYWYu-Chuan Wang
- Chia-Shin YangCYChia-Shin Yang
- Shao-Chun WangSWShao-Chun Wang
- Mien-Chie HungMHMien-Chie Hung
Open Access
Abstract
In late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic emerged to severely impact the global population, creating an unprecedented need for effective treatments. This study aims to investigate the potential of Scutellaria barbata D. Don (SB) as a treatment for SARS-CoV-2 infection through the inhibition of the proteases playing important functions in the infection by SARS-CoV-2. FRET assay was applied to investigate the inhibitory effects of SB on the two proteases involved in SARS-CoV-2 infection, Mpro and TMPRSS2. Additionally, to measure the potential effectiveness of SB treatment on infection inhibition, cellular models based on the Calu3 and VeroE6 cells and their TMPRSS2- expressing derivatives were assessed by viral pseudoparticles (Vpp) infection assays. The experimental approaches were conjugated with LC/MS analyses of the aqueous extracts of SB to identify the major constituent compounds, followed by a literature review to determine the potential active components of the inhibitory effects on protease activities. Our results showed that SB extracts inhibited the enzyme activities of Mpro and TMPRSS2. Furthermore, SB extracts effectively inhibited SARS-CoV-2 Vpp infection through a TMPRSS2-dependent mechanism. The aqueous extract analysis identified six major constituent compounds present in SB. Some of them have been known associated with inhibitory activities of TMPRSS2 or Mpro. Thus, SB may effectively prevent SARS-CoV-2 infection and replication through inhibiting Mpro and TMPRSS2 protease activities.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan ((MOST 109-2327-B-039-003 (M.-C.H)))
- China Medical University Hospital ((DMR-109-199, DMR-110-004, DMR-110-009 and CRS-108-001 (S.-T.H)))
- Chinese Medicine Research Center, China Medical University, under the Higher Education Sprout Project, Ministry of Education, Taiwan ((CMRC-CHM-1 (S.-T.H)))
This publication has 85 references indexed in Scilit:
- A dual character of flavonoids in influenza A virus replication and spread through modulating cell-autonomous immunity by MAPK signaling pathwaysScientific Reports, 2014
- Apigenin Inhibits Enterovirus-71 Infection by Disrupting Viral RNA Association with trans-Acting FactorsPLOS ONE, 2014
- Scutellaria barbata inhibits angiogenesis through downregulation of HIF‐1 α in lung tumorEnvironmental Toxicology, 2012
- Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibitionBioorganic & Medicinal Chemistry, 2010
- Simultaneous determination of 7 active ingredients in Scutellaria barbata D. Don by capillary micellar electrokinetic chromatographyChinese Journal of Chromatography, 2010
- Apolipoprotein B–dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringeninHepatology, 2008
- Antitumor activity of chloroform fraction of Scutellaria barbata and its active constituentsPhytotherapy Research, 2007
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host CellsJournal of Virology, 2004
- Chemical composition and antimicrobial activity of the essential oil of Scutellaria barbataPhytochemistry, 2004